ストックスクリーナーアプリを入手
1.32
5.04%
-0.07
前日終値:
$1.39
開ける：
$1.39
24時間の取引高:
163.74K
Relative Volume:
0.39
時価総額：
$79.96M
収益：
-
当期純損益:
$-64.86M
株価収益率:
-1.1786
EPS:
-1.12
ネットキャッシュフロー:
$-55.66M
1週間 パフォーマンス:
-8.33%
1か月 パフォーマンス:
+4.76%
6か月 パフォーマンス:
+3.13%
1年 パフォーマンス:
-46.12%
1日の値動き範囲:
$1.30
$1.39
1週間の範囲:
$1.30
$1.47
52週間の値動き範囲:
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
名前
Acumen Pharmaceuticals Inc
セクター
電話
617-344-4190
住所
1210-1220 WASHINGTON STREET, NEWTON
ABOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
1.32 | 81.77M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-17 | 開始されました | Citigroup | Buy |
| 2024-07-26 | 開始されました | Citigroup | Buy |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-07-20 | 再開されました | BofA Securities | Buy |
| 2023-05-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 開始されました | BTIG Research | Buy |
| 2022-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-07-26 | 開始されました | BofA Securities | Neutral |
| 2021-07-26 | 開始されました | Credit Suisse | Outperform |
| 2021-07-26 | 開始されました | Stifel | Buy |
| 2021-07-26 | 開始されました | UBS | Buy |
すべてを表示
Acumen Pharmaceuticals Inc (ABOS) 最新ニュース
What data driven models say about Acumen Pharmaceuticals Inc.’s futureQuarterly Profit Review & AI Powered Market Trend Analysis - Newser
Acumen Pharmaceuticals’ Earnings Call Highlights Strategic Growth - MSN
Is Acumen Pharmaceuticals Inc. still worth holding after the dipEarnings Growth Summary & Weekly Market Pulse Updates - Newser
Combining machine learning predictions for Acumen Pharmaceuticals Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Predicting Acumen Pharmaceuticals Inc. trend using moving averagesInsider Selling & AI Powered Market Trend Analysis - Newser
What recovery options are there for Acumen Pharmaceuticals Inc.July 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
Will Acumen Pharmaceuticals Inc. bounce back from current supportBull Run & Weekly High Momentum Picks - Newser
What earnings revisions data tells us about Acumen Pharmaceuticals Inc.Earnings Summary Report & Breakout Confirmation Trade Signals - Newser
Live market analysis of Acumen Pharmaceuticals Inc.2025 Performance Recap & Technical Pattern Based Signals - Newser
Risk vs reward if holding onto Acumen Pharmaceuticals Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser
Using flow based indicators on Acumen Pharmaceuticals Inc.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser
Technical signs of recovery in Acumen Pharmaceuticals Inc.July 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - Newser
Building trade automation scripts for Acumen Pharmaceuticals Inc.Portfolio Gains Report & High Win Rate Trade Alerts - Newser
Can you recover from losses in Acumen Pharmaceuticals Inc.2025 Sector Review & Consistent Profit Trading Strategies - Newser
Leading vs lagging indicators on Acumen Pharmaceuticals Inc. performance2025 Biggest Moves & Short-Term Trading Opportunity Alerts - Newser
Will Acumen Pharmaceuticals Inc. price bounce be sustainableJuly 2025 EndofMonth & Daily Profit Focused Screening - Newser
Should you wait for a breakout in Acumen Pharmaceuticals Inc.Earnings Risk Summary & Reliable Price Breakout Signals - Newser
Can machine learning forecast Acumen Pharmaceuticals Inc. recovery2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
What MACD signals say about Acumen Pharmaceuticals Inc.Trade Analysis Report & AI Powered Buy/Sell Recommendations - Newser
Multi factor analysis applied to Acumen Pharmaceuticals Inc2025 Top Gainers & Safe Entry Momentum Tips - Newser
Can a trend reversal in Acumen Pharmaceuticals Inc. lead to recoveryJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
What institutional flow reveals about Acumen Pharmaceuticals Inc.New Guidance & Safe Entry Momentum Tips - Newser
Is Acumen Pharmaceuticals Inc. stock ready for a breakoutWeekly Trade Recap & Daily Profit Maximizing Tips - Newser
Technical analysis overview for Acumen Pharmaceuticals Inc. stockJuly 2025 Sector Moves & Growth Focused Entry Reports - Newser
Can Acumen Pharmaceuticals Inc. recover in the next quarterJuly 2025 Selloffs & Free Community Consensus Stock Picks - Newser
Tick level data insight on Acumen Pharmaceuticals Inc. volatilityMarket Movers & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-09-09 05:33:01 - Newser
Acumen Pharmaceuticals Inc (ABOS) 財務データ
収益
当期純利益
現金流量
EPS
Acumen Pharmaceuticals Inc (ABOS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
| Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):